Borges P, Martins C, Stocco C, Zuber J, Borges W, Muller E
Rev Esc Enferm USP. 2025; 58:e20240098.
PMID: 40047528
PMC: 11884405.
DOI: 10.1590/1980-220X-REEUSP-2024-0098en.
Cola J, do Prado T, Alves B, Sales C, Borges B, Mascarello K
BMC Infect Dis. 2025; 25(1):301.
PMID: 40025419
PMC: 11874625.
DOI: 10.1186/s12879-025-10678-z.
Souza S, Gonzales R, Sthal H, Silva D, Barbosa M, Conceicao T
Rev Bras Enferm. 2024; 77(5):e20230477.
PMID: 39699417
PMC: 11654224.
DOI: 10.1590/0034-7167-2023-0477.
Sharafi M, TalebiMoghaddam M, Narouee S, Heiran A, Khaleghi M, Mouseli A
BMC Health Serv Res. 2024; 24(1):1489.
PMID: 39604982
PMC: 11603852.
DOI: 10.1186/s12913-024-11959-0.
Belchior A, Freitas Neto A, Gusmao G, Santos E, Ferreira Lemos E, Pompilio M
Rev Inst Med Trop Sao Paulo. 2024; 66:e65.
PMID: 39536219
PMC: 11556834.
DOI: 10.1590/S1678-9946202466065.
The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020-2023.
Marco M, Ahmedov S, Castro K
PLOS Glob Public Health. 2024; 4(7):e0003043.
PMID: 38959278
PMC: 11221697.
DOI: 10.1371/journal.pgph.0003043.
The impact of the SARS-CoV-2 pandemic on tuberculosis notifications and deaths in the state of São Paulo, Brazil: a cross-sectional study.
Blume M, Waldman E, Lindoso A, Rujula M, Orlandi G, Oliveira M
Lancet Reg Health Am. 2024; 34:100765.
PMID: 38841150
PMC: 11152648.
DOI: 10.1016/j.lana.2024.100765.
[Temporal trend in the evaluation of adequate management for diagnosis and treatment of tuberculosis in primary health care in Brazil (2012-2018)].
Picanco L, Dutra R, de Oliveira Saes M
Cad Saude Publica. 2024; 40(3):e00087723.
PMID: 38477729
PMC: 10929882.
DOI: 10.1590/0102-311XPT087723.
Unsuccessful tuberculosis treatment outcomes across Brazil's geographical landscape before and during the COVID-19 pandemic: are we truly advancing toward the sustainable development/end TB goal?.
Tavares R, Berra T, Alves Y, Popolin M, Ramos A, Tartaro A
Infect Dis Poverty. 2024; 13(1):17.
PMID: 38369536
PMC: 10874548.
DOI: 10.1186/s40249-024-01184-6.
Spatial-temporal evolution of tuberculosis incidence rates in indigenous and non-indigenous people of Brazil, from 2011 to 2022.
Vaz I, Paiva N, Viana P
Rev Bras Epidemiol. 2023; 26:e230055.
PMID: 38088714
PMC: 10715319.
DOI: 10.1590/1980-549720230055.
Factors Associated with Tuberculosis Outcome in a Hyperendemic City in the North of Brazil.
Costa G, Garcez J, Marcos W, Ferreira A, Andrade J, Rodrigues Y
Healthcare (Basel). 2023; 11(4).
PMID: 36833042
PMC: 9957009.
DOI: 10.3390/healthcare11040508.
Impact of COVID-19 Pandemic on Tuberculosis Preventive Services and Their Post-Pandemic Recovery Strategies: A Rapid Review of Literature.
Jeong Y, Min J
J Korean Med Sci. 2023; 38(5):e43.
PMID: 36747365
PMC: 9902666.
DOI: 10.3346/jkms.2023.38.e43.
The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?.
de Barros G
Einstein (Sao Paulo). 2022; 20:eCE0196.
PMID: 36449760
PMC: 9744428.
DOI: 10.31744/einstein_journal/2022CE0196.
Impact of COVID-19 on Tuberculosis Indicators in Brazil: A Time Series and Spatial Analysis Study.
Berra T, Ramos A, Alves Y, Tavares R, Tartaro A, Nascimento M
Trop Med Infect Dis. 2022; 7(9).
PMID: 36136658
PMC: 9500936.
DOI: 10.3390/tropicalmed7090247.
Effects of COVID-19 on tuberculosis control: past, present, and future.
Silva D, Mello F, Migliori G
J Bras Pneumol. 2022; 48(2):e20220102.
PMID: 35584470
PMC: 9064613.
DOI: 10.36416/1806-3756/e20220102.
